Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q2 2023 Earnings Call Transcript

Operator: Thank you for standing by, and welcome to the Nautilus Biotechnology Second Quarter 2023 Earnings Conference Call. [Operator Instructions] As a reminder, today's program is being recorded.

Related Keywords

Busan ,Pusan Gwangyoksi ,South Korea ,California ,United States ,San Diego ,San Carlos ,Carrie Mendivil ,Sujal Patel ,Daniel Brennan ,Dave Delahunt ,Yuko Oku ,Dan Brennan ,Anna Mowry ,Parag Mallick ,Ruedi Aebersold ,Nasdaq ,Human Proteome Organization International Congress ,Human Proteome Organization Show ,European Proteomics Association Conference ,World Congress ,Genentech ,Morgan Stanley ,Human Proteome Organization Annual Meeting ,Alzheimer Association International Conference ,Nautilus Biotechnology Inc ,Goldman Sachs ,Nautilus Biotechnology ,Call Transcript August ,Nautilus Biotechnology Second Quarter ,Carrie Mendivil Investor ,Chief Scientist ,Chief Financial ,Bay Area ,Association International Conference ,Human Proteome Organization ,Annual Meeting ,Nautilus Scientific Advisory Board ,Genome Analyzer ,Hiseqx Ten ,Illumina Genome Analyzer ,Tejas Savant ,Maybei Ll ,